CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Star Combo Pharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Star Combo Pharma Ltd
Smithfield, 171 - 177 Woodpark Road
Phone: +61 297566555p:+61 297566555 Sydney, NSW  2164  Australia Ticker: S66S66

Business Summary
Star Combo Pharma Limited is an Australia-based company that is primarily engaged in the manufacture and distribution of health and natural beauty products. The Company operates through two segments: Star Combo business and Austoyou retail. The Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment is made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers. The Company’s product categories include Costar, Living Healthy, Amax and J&K. The Company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance. The Company’s wholly owned subsidiaries include CoStar Pharma Laboratory Pty Ltd and Star Combo Australia Pty Ltd.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20236/30/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board RichardAllely 1/1/2018 1/1/2018
Chief Executive Officer, Director SuZhang
Chief Financial Officer JamesNi 6/9/2022 6/9/2022
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 135,082,901 (As of 12/31/2023)
Shareholders: 570
Stock Exchange: ASX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024